Transcatheter hepatic arterial chemoembolization and sorafenib for hepatocellular carcinoma: a meta-analysis of randomized, double-blind controlled trials

We performed a meta-analysis of transcatheter hepatic arterial chemoembolization (TACE) combined with sorafenib for hepatocellular carcinoma (HCC), which included 4 double-blind, randomized controlled trials (RCTs) that investigated the effects of TACE combined with sorafenib (experimental groups) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun, Liu, Wenhui, Zhu, Wenhua, Wu, Yinqiao, Wu, Benyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601759/
https://www.ncbi.nlm.nih.gov/pubmed/28938663
http://dx.doi.org/10.18632/oncotarget.19334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601759/
https://www.ncbi.nlm.nih.gov/pubmed/28938663
http://dx.doi.org/10.18632/oncotarget.19334

Ejemplares similares